Deciphera Pharmaceuticals, Inc. Costs and Expenses
Deciphera Pharmaceuticals, Inc. reported Costs and Expenses of $93.85 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2024-05-10
- Deciphera Pharmaceuticals, Inc. costs and expenses for the quarter ending 2024-03-31 was $93.85M, a 8.24% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. costs and expenses for the quarter ending 2023-12-31 was $99.53M, a 19.19% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. costs and expenses for the quarter ending 2023-09-30 was $97.00M, a 19.97% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. costs and expenses for the quarter ending 2023-06-30 was $91.08M, a 19.40% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. costs and expenses for fiscal 2023 was $374.31M, a 18.17% increase from fiscal 2022.
- Deciphera Pharmaceuticals, Inc. costs and expenses for fiscal 2022 was $316.76M, a 20.06% decline from fiscal 2021.
- Deciphera Pharmaceuticals, Inc. costs and expenses for fiscal 2021 was $396.23M, a 26.48% increase from fiscal 2020.
- Deciphera Pharmaceuticals, Inc. costs and expenses for fiscal 2020 was $313.28M, a 38.79% increase from fiscal 2019.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2024-03-31 | $93.85M 10-Q · filed 2024-05-10 | $193.38M derived: sum of 2 quarters · filed 2024-05-10 | $290.38M derived: sum of 3 quarters · filed 2024-05-10 | $381.46M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | $99.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $196.53M derived: sum of 2 quarters · filed 2024-02-07 | $287.61M derived: sum of 3 quarters · filed 2024-02-07 | $374.31M 10-K · filed 2024-02-07 |
| 2023-09-30 | $97.00M 10-Q · filed 2023-10-30 | $188.08M derived: sum of 2 quarters · filed 2023-10-30 | $274.78M 10-Q · filed 2023-10-30 | $358.29M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-06-30 | $91.08M 10-Q · filed 2023-08-09 | $177.78M 10-Q · filed 2023-08-09 | $261.29M derived: sum of 3 quarters · filed 2024-05-10 | $342.14M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | $86.70M 10-Q · filed 2024-05-10 | $170.21M derived: sum of 2 quarters · filed 2024-05-10 | $251.06M derived: sum of 3 quarters · filed 2024-05-10 | $327.35M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $83.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $164.36M derived: sum of 2 quarters · filed 2024-02-07 | $240.64M derived: sum of 3 quarters · filed 2024-02-07 | $316.76M 10-K · filed 2024-02-07 |
| 2022-09-30 | $80.86M 10-Q · filed 2023-10-30 | $157.14M derived: sum of 2 quarters · filed 2023-10-30 | $233.25M 10-Q · filed 2023-10-30 | $345.85M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $76.28M 10-Q · filed 2023-08-09 | $152.40M 10-Q · filed 2023-08-09 | $265.00M derived: sum of 3 quarters · filed 2024-02-07 | $367.88M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $76.11M 10-Q · filed 2023-05-03 | $188.72M derived: sum of 2 quarters · filed 2024-02-07 | $291.60M derived: sum of 3 quarters · filed 2024-02-07 | $385.69M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $112.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $215.49M derived: sum of 2 quarters · filed 2024-02-07 | $309.57M derived: sum of 3 quarters · filed 2024-02-07 | $396.23M 10-K · filed 2024-02-07 |
| 2021-09-30 | $102.89M 10-Q · filed 2022-11-03 | $196.97M derived: sum of 2 quarters · filed 2022-11-03 | $283.63M 10-Q · filed 2022-11-03 | $366.11M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $94.09M 10-Q · filed 2022-08-04 | $180.74M 10-Q · filed 2022-08-04 | $263.22M derived: sum of 3 quarters · filed 2023-02-07 | $342.67M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $86.65M 10-Q · filed 2022-05-04 | $169.13M derived: sum of 2 quarters · filed 2023-02-07 | $248.58M derived: sum of 3 quarters · filed 2023-02-07 | $324.60M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $82.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $161.93M derived: sum of 2 quarters · filed 2023-02-07 | $237.95M derived: sum of 3 quarters · filed 2023-02-07 | $313.28M 10-K · filed 2023-02-07 |
| 2020-09-30 | $79.45M 10-Q · filed 2021-11-02 | $155.47M derived: sum of 2 quarters · filed 2021-11-02 | $230.79M 10-Q · filed 2021-11-02 | $301.17M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $76.02M 10-Q · filed 2021-08-03 | $151.35M 10-Q · filed 2021-08-03 | $221.72M derived: sum of 3 quarters · filed 2022-02-08 | $280.07M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $75.32M 10-Q · filed 2021-05-04 | $145.70M derived: sum of 2 quarters · filed 2022-02-08 | $204.05M derived: sum of 3 quarters · filed 2022-02-08 | $252.03M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $70.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $128.73M derived: sum of 2 quarters · filed 2022-02-08 | $176.70M derived: sum of 3 quarters · filed 2022-02-08 | $225.73M 10-K · filed 2022-02-08 |
| 2019-09-30 | $58.35M 10-Q · filed 2020-11-05 | $106.33M derived: sum of 2 quarters · filed 2020-11-05 | $155.35M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $47.98M 10-Q · filed 2020-08-04 | $97.00M 10-Q · filed 2020-08-04 | ||
| 2018-12-31 | $104.10M 10-K · filed 2021-02-09 |